Mainz, October 7, 2013 – At BIOTECHNICA 2013 in Hannover (October 8-10), TRON researchers Dr. Cedrik Britten and Dr. Valesca Boisguérin will present methods and platforms for personalized cancer diagnostics and therapeutics that are researched and developed at TRON.
- On October 8, 16:30 to 17:00, Cedrik Britten, TRON Group Leader Cell-Mediated Immunity, will talk about “Cellular Immune Assays to Guide the Clinical Development of Novel (Cancer-) Immunotherapies”.
- On October 9, 10:00-10:30, Valesca Boisguérin, Head of Medical Genomics at TRON, will give an overview of “NGS for Individualized Cancer Therapeutics”.
The BIOTECHNICA Marketplace “Personalized Medicine Technologies” offers technology providers and users with new scientific finding and technologies.
For more information click here.